Aoxing Pharma Names Dr. James Chen as CFO

Aoxing Pharmaceutical Company, Inc. (NYSE MKT:

) today announced that Dr. James Chen has joined the Company as Chief Financial Officer, effective as of February 1, 2016. Mr. Guoan Zhang, who had served as Interim CFO,  will continue to serve as Vice President - Finance and Controller for the Company, Before joining Aoxing Parma, Dr. Chen was the CFO of Origin Agritech. At Origin, he successfully managed both operational and finance functions, and helped Origin to weather one of the worst years in the Chinese seed industry.  He was instrumental in bringing Origin's technologies to global cooperation programs and in  entering the seeds and traits market in the United States. Prior to working at Origin, Dr. Chen served as an Investment Manager at the Abu Dhabi Investment Authority (ADIA), the sovereign wealth fund owned by the Government of Abu Dhabi. In his investment manager capacity, Dr. Chen played a key role in managing equity investment in China-related portfolios. After joining ADIA in 2008, he contributed significantly in setting up the